跳转至内容
Merck
CN

C8249

小豆蔻明

≥98% (HPLC),  glycogen synthase kinase 3 (GSK3) inhibitor, powder

别名:

(2E)-1-(2,4-二羟基-6-甲氧基苯基)-3-苯基-2-丙烯-1-酮, (8CI);川陈皮素查尔酮, (E)-2′,4′-二羟基-6′-甲氧基查尔酮

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C16H14O4
化学文摘社编号:
分子量:
270.28
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

小豆蔻明, ≥98% (HPLC)

SMILES string

O=C(/C=C/C1=CC=CC=C1)C2=C(O)C=C(O)C=C2OC

InChI key

NYSZJNUIVUBQMM-BQYQJAHWSA-N

InChI

1S/C16H14O4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19H,1H3/b8-7+

assay

≥98% (HPLC)

form

powder

color

light yellow to dark brown

solubility

DMSO: ≥20 mg/mL

storage temp.

room temp

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

小豆蔻明已被用作糖原合酶激酶3(GSK3)抑制剂,用于研究其对植入前人胚胎中β-连环蛋白功能缺失和获得(loss and gain-of-function)的影响。
小豆蔻明已被用作高效液相色谱(HPLC)分析金合欢(acacia)蜂蜜样品中酚类化合物中的标准品。

Biochem/physiol Actions

小豆蔻醚 (Cardamonin) 是一种来自豆蔻属(姜科植物)的查耳酮。
小豆蔻醚 (Cardamonin) 是一种来自豆蔻属(姜科植物)的植物。小豆蔻醚通过抑制 Wnt/β-连环蛋白 信号通路抑制黑素细胞色素沉着。小豆蔻醚通过蛋白酶体介导降解 β-连环蛋白(GSK-3β 非依赖性途径)抑制 Wnt/β-连环蛋白信号通路。研究表明,小豆蔻醚通过抑制 NF-kB 核转位和 Ik-Ba 磷酸化而具有抗炎活性。

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Ying Liu et al.
BMC complementary medicine and therapies, 23(1), 336-336 (2023-09-26)
mTORC1 (mechanistic target of rapamycin complex 1) is associated with lymphoma progression. Oncogenic RRAGC (Rag guanosine triphosphatase C) mutations identified in patients with follicular lymphoma facilitate the interaction between Raptor (regulatory protein associated with mTOR) and Rag GTPase. It promotes
Qiushi Xu et al.
Frontiers in pharmacology, 11, 601716-601716 (2020-12-29)
Cardamonin (CD), a naturally occurring chalcone derived from the Alpinia species, has been shown to exert antioxidant and anti-inflammatory activity, but its role in the prevention of acetaminophen- (APAP-) induced hepatotoxicity remains elusive. The objective of this study was to
Peiguang Niu et al.
Oncology letters, 15(3), 3991-3997 (2018-02-20)
The mammalian target of rapamycin (mTOR) is well-known as a promising therapeutic target in various cancer cells. mTOR activation decreases the sensitivity of ovarian cancer to cisplatin. Cardamonin inhibits the proliferation of various cancer cells by mTOR suppression. The present
Bokyung Sung et al.
PloS one, 8(5), e64118-e64118 (2013-05-22)
Bone loss/resorption or osteoporosis is a disease that is accelerated with aging and age-associated chronic diseases such as cancer. Bone loss has been linked with human multiple myeloma, breast cancer, and prostate cancer and is usually treated with bisphosphonates, and
Jianqing Jiang et al.
Journal of microbiology and biotechnology, 31(6), 794-802 (2021-05-25)
In this study we investigated the role and mechanism of cardamonin on IL-1β induced injury in OA. CHON-001 cells were treated with cardamonin and IL-1β and transfected with silencing nuclear factor erythroid 2-related factor 2 (siNrf2). Cell viability was detected

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持